Schizophrenia
Welcome,         Profile    Billing    Logout  
 86 Companies   137 Products   137 Products   85 Mechanisms of Action   4 Trials   2019 News 


«12...7891011121314151617...3940»
  • ||||||||||  Aristada once-monthly (aripiprazole lauroxil once-monthly formulation) / Alkermes
    Trial completion:  OLE: A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) (clinicaltrials.gov) -  May 19, 2015   
    P3,  N=478, Completed, 
    Recruiting --> Completed | Trial primary completion date: Feb 2015 --> Mar 2014 Active, not recruiting --> Completed
  • ||||||||||  Abilify Maintena (aripiprazole extended release) / Otsuka, Lundbeck
    Trial completion:  Aripiprazole Once-monthly in Patients With Schizophrenia (clinicaltrials.gov) -  May 12, 2015   
    P3,  N=88, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed
  • ||||||||||  Enrollment change, Trial withdrawal:  Usability of a Website for People With Schizophrenia (clinicaltrials.gov) -  May 7, 2015   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Completed | N=420 --> 524 | Trial primary completion date: May 2016 --> Feb 2015 N=75 --> 0 | Terminated --> Withdrawn
  • ||||||||||  Enrollment change, Trial primary completion date:  Effects of Systematic Patient Feedback on Therapy Outcome (clinicaltrials.gov) -  May 6, 2015   
    P=N/A,  N=170, Recruiting, 
    Active, not recruiting --> Completed | Initiation date: Feb 2012 --> Jan 2013 | Trial primary completion date: Oct 2014 --> Apr 2014 N=120 --> 170 | Trial primary completion date: Jun 2016 --> Jun 2018
  • ||||||||||  Trial completion:  Nonconvulsive Electrotherapy: a Proof-of-concept Trial (clinicaltrials.gov) -  May 6, 2015   
    P1,  N=13, Completed, 
    N=120 --> 170 | Trial primary completion date: Jun 2016 --> Jun 2018 Active, not recruiting --> Completed
  • ||||||||||  Daliresp (roflumilast) / AstraZeneca, Takeda, AbbVie
    Enrollment closed, Trial primary completion date:  Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia (clinicaltrials.gov) -  May 5, 2015   
    P1,  N=20, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Jun 2015
  • ||||||||||  Doria (risperidone extended release) / ROVI Pharmaceuticals Laboratories
    Trial completion:  PRISMA-2: Pharmacokinetics and Tolerability Study of Risperidone ISM (clinicaltrials.gov) -  May 5, 2015   
    P2,  N=70, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Jun 2015 Active, not recruiting --> Completed
  • ||||||||||  Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J
    Trial primary completion date:  ACLAIMS: A Comparison of Long-acting Injectable Medications for Schizophrenia (clinicaltrials.gov) -  May 2, 2015   
    P4,  N=311, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2013 --> Jul 2013
  • ||||||||||  risperidone / Generic mfg.
    Trial primary completion date:  Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia (clinicaltrials.gov) -  Apr 29, 2015   
    P2,  N=282, Completed, 
    Trial primary completion date: Dec 2013 --> Jul 2013 Trial primary completion date: Jan 2009 --> Oct 2005
  • ||||||||||  Enrollment closed:  AHCM: Addiction Housing Case Management for Homeless Veterans (clinicaltrials.gov) -  Apr 22, 2015   
    P=N/A,  N=400, Active, not recruiting, 
    Trial primary completion date: Dec 2015 --> Sep 2016 Recruiting --> Active, not recruiting
  • ||||||||||  Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly
    Trial primary completion date:  Linagliptin in Schizophrenia Patients (clinicaltrials.gov) -  Apr 20, 2015   
    P1,  N=5, Recruiting, 
    N=78 --> 36 Trial primary completion date: Oct 2014 --> Oct 2016
  • ||||||||||  risperidone / Generic mfg., desipramine / Generic mfg.
    Trial completion, Enrollment change:  RADIAUS: Risperidone and Desipramine in Alcohol Use and Schizophrenia (clinicaltrials.gov) -  Apr 20, 2015   
    P2,  N=12, Completed, 
    Trial primary completion date: Oct 2014 --> Oct 2016 Active, not recruiting --> Completed | N=40 --> 12
  • ||||||||||  Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
    Trial primary completion date:  Kuvan in People With Schizophrenia and Schizoaffective Disorder (clinicaltrials.gov) -  Apr 19, 2015   
    P1/2,  N=60, Suspended, 
    Active, not recruiting --> Completed | N=40 --> 12 Trial primary completion date: Jun 2014 --> Sep 2015
  • ||||||||||  Enrollment open, Trial initiation date, Trial primary completion date:  A Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in Ethiopia (clinicaltrials.gov) -  Apr 16, 2015   
    P4,  N=240, Recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Oct 2009 --> Oct 2014 Not yet recruiting --> Recruiting | Initiation date: Jun 2014 --> Nov 2014 | Trial primary completion date: Jun 2015 --> Jun 2016
  • ||||||||||  Trial initiation date, Trial primary completion date:  RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) (clinicaltrials.gov) -  Apr 14, 2015   
    P=N/A,  N=180, Not yet recruiting, 
    Trial primary completion date: Nov 2016 --> Feb 2017 Initiation date: Mar 2015 --> Jun 2015 | Trial primary completion date: Dec 2015 --> Mar 2016
  • ||||||||||  methylphenidate prolonged release tablet - 12 hrs acting / Generic mfg.
    Trial completion, Combination therapy:  A Study of Combination Therapy in Children With ADHD (clinicaltrials.gov) -  Apr 10, 2015   
    P4,  N=99, Completed, 
    N=52 --> 34 Active, not recruiting --> Completed
  • ||||||||||  iloperidone / Generic mfg.
    Enrollment closed, Trial primary completion date:  Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients (clinicaltrials.gov) -  Apr 9, 2015   
    P1,  N=29, Active, not recruiting, 
    Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Aug 2015
  • ||||||||||  Trial completion:  A Definitive Estrogen Patch Study (ADEPT) (clinicaltrials.gov) -  Apr 1, 2015   
    P2,  N=180, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  citalopram / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date, HEOR, Cost effectiveness:  ACTIONS: Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia (clinicaltrials.gov) -  Mar 26, 2015   
    P4,  N=62, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=358 --> 62 | Trial primary completion date: Jan 2014 --> Dec 2014